Jim Stronski is a partner in the New York office of Crowell & Moring, and a member of the Intellectual Property Group, where he serves on its Steering Committee. He also is a member of the Trade Secrets Working Group, and the Litigation & Trial Department. Jim is a first-chair trial lawyer who concentrates his practice in IP litigation and related commercial disputes, as well as advice on trademarks and related licensing issues and disputes. He has litigated in courts nationwide for over 25 years. Jim has been listed in the New York Super Lawyers Metro Edition for intellectual property litigation each year since 2006.
Jim’s practice includes patent litigation, trade secret litigation and counseling and trademark and false advertising litigation and counseling and copyright litigation. Jim also represents pharmaceutical companies concerning patent, regulatory and commercial obstacles to the commercialization of generic or biosimilar products, as well as in related commercial and licensing disputes.
Jim has first chaired cases at the PTO before the Trademark Trial and Appeal Board, including through trial, and advises clients on trademark infringement and clearance issues. Jim has served on the Editorial Board of the International Trademark Association's Trademark Reporter and has served as a moot court judge through several organizations, including the International Trademark Association.
Jim serves on the firm’s Public Service Committee. He has been active representing individuals on death row, challenging convictions and challenging methods and protocols used in executions. This work and the work of a many others at Crowell was recognized in the firm’s receipt of the 2018 Exceptional Service Award from the ABA’s Death Penalty Project
Jim was Law Clerk to the Honorable Judge Shirley Wohl Kram, U.S. District Court, Southern District of New York, from 1988-1990.
Representative Matters
- Waters Corporation, et al. v. Agilent Technologies, Inc., 18 civ. 01450 (MN), U.S. District Court for the District of Delaware (2018 to present)
- Arch Chemicals, Inc. v. Sherwin Williams, 18 civ. 2037 (LPS), U.S. District Court for the District of Delaware (2018 to present)
- Cellular Dynamics, Intl. v. Lonza Walkersville, 17 civ. 2713 (CCB), U.S. District Court for the District of Maryland (2017 to present)
- Onyx Therapeutics v. CIPLA, Ltd., et al., 16 civ 00988 (LPS), U.S. District Court for the District of Delaware (2016 to 2019)
- Delcor Asset Corporation and Prestium Pharma, Inc. v. Taro Pharmaceutical Industries, Ltd., et al., No. 16-117-UNA, U.S. District Court for the District of Delaware (2016 to 2017)
- In re CIPRODEX, Consolidated Civil Action No. 3:15-cv-05756 (PGS) (DEA), U.S. District Court for the District of New Jersey (2016 to 2018)
- Noven Pharmaceuticals, Inc. v. Actavis Laboratories UT, Inc., No. 15-249-LPS, U.S. District Court for the District of Delaware (2015 to present)
- Shenanzhu LLC d/b/a The Diner v. Cambria Company LLC, et al., 15 CV 00338 (WHP), U.S. District Court for the Southern District of New York (2015 to 2017)
- Cephalon, Inc. v. Actavis Laboratories FL, Inc. et al., No.14-776-SLR-SRF, .U.S. District Court for the District of Delaware (2014 to 2015)
- State of Ohio v. Apanovitch, CR 84: 194156, Court of Common Pleas, Cuyahoga County, Ohio (2012 to present)
- Pfizer Inc. et al. v. Actavis Laboratories FL, Inc., No. 11-914, U.S. District Court for the District of Delaware. (2012-2014)
- Multilayer Stretch Cling Film Holdings, Inc. v. MSC Marketing and Technology, Inc., et al, No. 2:12 cv 02112, U.S. District Court for the Western District of Tennessee (2012-2014)
- Takeda Pharmaceutical Co., Ltd et al. v. Handa Pharmaceuticals, LLC and Par Pharmaceutical, Inc., No. 3:11-840 U.S. District Court for the Northern District of California (2012-2014)
- Handa Pharmaceuticals, LLC and Par Pharmaceutical, Inc. v. Takeda Pharmaceutical Co., Ltd et al. v., No. 5:13-1927, U.S. District Court for the Northern District of California (2013-2014)
- Shire Development, LLC v. Watson Pharmaceuticals, Inc., U.S. District Court for the Southern District of Florida (2012-2013)
- Sanofi Aventis US LLC, et al. V. Watson Pharmaceuticals, Inc., No. 1:2153 (SDW)(MCA), U.S. District Court for the District of New Jersey (2011-2012)
- Cephalon, Inc. et al. v. Watson Pharmaceuticals, Inc. et al. (C.A. 08- 330-SLR; 09-724-SLR), U.S. District Court for the District of Delaware, 2008-2011
- Purdue Pharma L.P. et al. v. Mallinckrodt, Inc. (06-CV-13095), U.S. District Court for the Southern District of New York, 2008
- Reliant Pharmaceuticals, Inc. v. Par Pharmaceuticals, Inc. (C.A. 06-774- JJF), U.S. District Court for the District of Delaware, 2006-2008
- Glaxo SmithKline v. Spectrum Pharmaceuticals (05-99-GMS; 06-0558-GMS), U.S. District Court for the District of Delaware, 2006
- In re Rivastigmine Patent Litigation (MDL No. 1661), U.S. District Court for the Southern District of New York, 2004-2008
- Pliant Corporation v. MSC Marketing & Technology, Inc. (04-CV-3509 (JBZ)), U.S. District Court for the Northern District of Illinois, 2004-2007
- Cephalon, Inc. v. Carlsbad Technology, Inc. (05 CV 1089 (JCL)), U.S. District Court for the District of New Jersey, 2005-2006
- Lambertson Truex, Inc. v. Sibeu Handbags, Inc. (03 Civ. 4510 (JES)), U.S. District Court for the Southern District of New York, 2003
- Electronic Products Distribution, LLC v. Bio-Medical Research Ltd. (02 Civ. 00251 (JES)), U.S. District Court for the Southern District of New York, 2002-2005
- Medichem S.A. v. Rolabo S.L. (01 Civ. 3087 (JSR)), U.S. District Court for the Southern District of New York, 2001-2007
- Tokyo Electron Arizona, Inc. v. Discreet Industries Corporation, et al. (01-3245 (DRH)(WDW)), U.S. District Court for the Eastern District of New York, 2001-2004
- Ocean Pacific Apparel Corp., v. Rays Apparel, Inc. (01 Civ. 7058 (KMW)), U.S. District Court for the Southern District of New York, 2001
- Minnesota Mining and Manufacturing Co. and Riker Laboratories, Inc. v. Alphapharm Pty. Ltd. (99-0013 (MJD/JL)), U.S. District Court for the District of Minnesota, 1999-2002
- SmithKline Beecham v. Watson Pharmaceuticals, et al. (99 Civ. 9214 (DC)), U.S. District Court for the Southern District of New York, 1999- 2000
- Granutec, Inc. v. Shalala (97-485-5-BO), U.S. District Court for the Eastern District of North Carolina, 1997-1998
Affiliations
Admitted to practice
Courts of the State of New York
U.S. District Court for the Southern District of New York
U.S. District Court for the Eastern District of New York
U.S. Court of Appeals for the Federal Circuit
U.S. Court of Appeals for the Second Circuit
U.S. Supreme Court
Professional Activities & Memberships
Jim is a member of several bar associations, including the Federal Bar Council and its Intellectual Property Committee and the Federal Bar Council's American Inn of Court where he serves as a Master.
Highlights, News & Knowledge
Speeches & Presentations
-
"Top 10 Tips for Safeguarding Trade Secrets," Crowell & Moring Webinar
(March 10, 2020).
Presenters: Anne Elise Herold Li, James K. Stronski, and Robert B. Kornweiss.
-
"China’s Economic Aggression Through the Acquisition (or Theft) of Foreign IP and DOJ’s China Initiative," Fordham Intellectual Property Law and Policy Conference, New York, NY
(April 25, 2019).
Presenter: James K. Stronski.
-
"Intellectual Property for the Micro-Entrepreneur," Legal Aid Society CLE at Crowell & Moring, New York, NY
(December 4, 2018).
Presenters: James K. Stronski and Preetha Chakrabarti.
-
"How to Play Nice with the District Court and Opposing Counsel During ANDA Litigation (Ethics CLE)," 32nd Annual Pharmaceutical and Chemical Patent Update, New Jersey Intellectual Property Law Association
(November 7, 2018).
Presenter: James K. Stronski.
-
"Intellectual Property for the Micro-Entrepreneur," Crowell & Moring, New York, NY
(December 13, 2017).
Presenters: James K. Stronski, Anne Elise Herold Li, and Preetha Chakrabarti.
-
“Criminal Prosecution of Trade Secret Theft Under the Economic Espionage Act, 18 USC 1831-37: a Trend in the Cybercrime Age," Fordham Intellectual Property Law and Policy Conference, New York, NY
(March 31, 2016).
Presenter: James K. Stronski.
-
"Timing is Everything: Managing the Logistics of the BPCIA Exchange Process and Preparing for "Early" and "Late" Phase Litigation," ACI - Biosimilars: The Definitive Forum on the Legal, Regulatory, Patent, and Commercial Realities of Biosimilars
(June 6, 2014).
Presenter: James K. Stronski.
-
"A Pros and Cons Analysis of Launch at Risk and Survey of New Developments in Seeking Injuctive Relief and Damages," American Conference Institute, 8th Annual Paragraph IV Disputes
(April 29, 2014).
Speaker: James K. Stronski.
-
"Inequitable Conduct Developments in the Courts and at the PTO: Ethical Considerations for Paragraph IV Cases," American Conference Institute, 7th Paragraph IV Disputes
(May 8, 2013).
Speaker: James K. Stronski.
-
"Updating the Standards in Inequitable Conduct Post-Therasense: Ethical Considerations for Paragraph IV Cases," American Conference Institute 3rd West Coast Edition Paragraph IV Disputes Conference, San Francisco, CA
(December 4-5, 2012).
Speaker: James K. Stronski.
-
"Eye on the Federal Circuit and District Courts: Life Cycle Lessons Derived from Paragraph IV Litigation," American Conference Institute's 11th Annual Maximizing Pharmaceutical Patent Life Cycles
(October 7, 2010).
Speaker: James K. Stronski.
-
"Eye on the Federal Circuit and District Courts: Life Cycle Lessons Derived from Paragraph IV Litigation," American Conference Institute's 10th Annual Maximizing Pharmaceutical Patent Life Cycles
(October 9, 2009).
Speaker: James K. Stronski.
-
Markman Hearings and Claim Construction in Patent Litigation 2008, Practicing Law Institute
(July 9, 2008).
Speaker: James K. Stronski.
-
"Preliminary Injunctions In Pharmaceutical Patent Litigation," American Conference Institute's Paragraph IV Disputes Conference
(May 1, 2008).
Speaker: James K. Stronski.
Publications
-
"Intellectual Property – TC Heartland Reshapes the Patent Litigation Landscape," Crowell & Moring's Litigation Forecast 2018
(January 2018).
Contributor: Jim Stronski.
-
"The New Standard for Copyright Protection Of Useful Articles: Star Athletica And Its Impact On The 3-D Printing Industry," Bloomberg BNA's Patent, Trademark and Copyright Journal
(July 14, 2017).
Authors: Preetha Chakrabarti, and James K. Stronski
-
"Not So Fast: Ex-Goldman Sachs Employee’s Conviction For Stealing Source Code Reinstated ," Crowell & Moring's Trade Secrets Trends
(January 25, 2017).
Authors: Preetha Chakrabarti, Anne Elise Herold Li, and James K. Stronski.
-
"When Customer Information Isn't a Trade Secret – McCormack Auction Company, Inc. v. Hanks," Crowell & Moring's Trade Secrets Trends
(June 1, 2016).
Authors: James K. Stronski and Jay DeSanto.
-
"Don't Hold Back: The FTC Attacks Endo for Agreeing to Delay Launch of an Authorized Generic," Bloomberg BNA's Pharmaceutical Law & Industry Report
(May 13, 2016).
Authors: Keith J. Harrison, James K. Stronski, Olivier N. Antoine, Astor Heaven, and Anne Elise Herold Li.
-
"Utah's Supreme Court Applies Rebuttable Presumption of Harm In Trade Secret Case," Crowell & Moring's Trade Secrets Trends
(September 2, 2015).
Author: James K. Stronski.
-
"The Federal Circuit Seeks to Rein in Inequitable Conduct in Therasense," BNA's Pharmaceutical Law & Industry Report
(July 1, 2011).
Co-Authors: James K. Stronski and Chiemi Suzuki.
Client Alerts & Newsletters
-
"Trade Secret Protection During the COVID-19 Pandemic,"
Trade Secrets Alert
(April 3, 2020).
Contacts: James K. Stronski, Anne Elise Herold Li, Robert B. Kornweiss
-
"CellZDirect: Hope for Life Science Patents,"
IP Insights
(July 12, 2016).
Contacts: James K. Stronski, Anne Elise Herold Li, Siri Rao
-
"Dancing Doesn’t Matter – Federal Circuit Said Biosimilar Companies Must Wait 180 Days,"
IP Insights
(July 11, 2016).
Contacts: Keith J. Harrison, James K. Stronski, Anne Elise Herold Li, Alex Rosen
-
"Don’t Hold Back: The FTC Attacks Endo for Agreeing to Delay Launch of an Authorized Generic,"
Antitrust Law Alert
(March 31, 2016).
Contacts: Keith J. Harrison, James K. Stronski, Olivier N. Antoine, Astor Heaven, Anne Elise Herold Li
-
"Four Takeaways for In-House Counsel from the Dec. 1 Amendments to the Federal Rules,"
IP Insights
(December 3, 2015).
Contacts: James K. Stronski, Ethan W. Simonowitz, Anne Elise Herold Li
-
"Federal Circuit Expands Direct Infringement Involving Multiple Actors,"
Intellectual Property Bullet Analyses
(August 14, 2015).
Contacts: James K. Stronski, Vincent J. Galluzzo, Anne Elise Herold Li
-
"Federal Circuit: 'Molecular Weight' Is Still Indefinite,"
IP Insights
(June 22, 2015).
Contacts: James K. Stronski, Anne Elise Herold Li
-
"District Court's Decision Paves the Way for the First U.S. Biosimilar,"
Life Sciences Alert
(March 23, 2015).
Contacts: Terry Rea, Keith J. Harrison, James K. Stronski, Anne Elise Herold Li, Mary Anne Schofield, Ph.D., Pilar Stillwater
-
"Three Take-Aways from Novartis' Historic First U.S. Biosimilar Approval ,"
Life Sciences Alert
(March 11, 2015).
Contacts: Terry Rea, Keith J. Harrison, James K. Stronski, Anne Elise Herold Li, Mary Anne Schofield, Ph.D., Pilar Stillwater
-
"First Final Written Decision in Inter Partes Review of Pharmaceutical Related Patents,"
IP Insights
(June 27, 2014).
Contacts: James K. Stronski, Terry Rea, Scott L. Bittman
Media Mentions
Firm News & Announcements